On Monday, BioTelemetry, Inc. (NASDAQ: BEAT) spotted trading -41.91% off 52-week high price. On the other end, the stock has been noted 26.82% away from the low price over the last 52-weeks. The stock changed -1.34% to recent value of $47.01. The stock transacted 219406 shares during most recent day however it has an average volume of 253.15K shares. The company has 33.32M of outstanding shares and 33.05M shares were floated in the market.
BioTelemetry, Inc. (BEAT) recently stated results for the third quarter ended September 30, 2019.
Third Quarter Financial Results
Revenue for the third quarter 2019 was $111.3M contrast to $100.0M for the third quarter 2018, a raise of $11.3M, or 11.3%.
Gross profit for the third quarter 2019 was $69.3M, or 62.3% of revenue, contrast to $62.7M, or 62.7% of revenue, for the third quarter 2018.
On a GAAP basis, net income attributable to BioTelemetry, Inc. for the third quarter 2019 was $8.3M, or $0.23 per diluted share, contrast to net income attributable to BioTelemetry, Inc. of $16.0M, or $0.45 per diluted share, for the third quarter 2018. The decline in net income attributable to BioTelemetry, Inc. is primarily Because of a $4.7M increase in income tax expense, with a previous year tax benefit from discrete items, as well as the ongoing investments in our salesforce and technology. While the Company’s predictable yearly effective tax rate is about 20%, as a result of the utilization of net operating loss carry forwards, the Company expects to use about $1-2M of cash for taxes in 2019.
On an adjusted basis1, net income attributable to BioTelemetry, Inc. for the third quarter 2019 was $18.8M, or $0.52 per diluted share. This compares to adjusted net income attributable to BioTelemetry, Inc. of $19.2M, or $0.53 per diluted share, for the third quarter 2018. The impact of the ongoing investments in our salesforce and technology is being offset by the revenue growth.
Its earnings per share (EPS) expected to touch remained 559.80% for this year while earning per share for the next 5-years is expected to reach at 25.00%. BEAT has a gross margin of 62.30% and an operating margin of 13.60% while its profit margin remained 9.00% for the last 12 months. According to the most recent quarter its current ratio was 2.5 that represents company’s ability to meet its current financial obligations. The price moved ahead of 3.73% from the mean of 20 days, 11.31% from mean of 50 days SMA and performed -4.04% from mean of 200 days price. Company’s performance for the week was 1.84%, 5.52% for month and YTD performance remained -21.28%.